<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2020-11-2-102-110</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-1068</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Анализ взаимосвязей между показателями эндотелий-зависимой вазодилатации и уровнем высокочувствительного C-реактивного белка и фракталкина/CX3CL1 у пациентов с острым коронарным синдромом</article-title><trans-title-group xml:lang="en"><trans-title>Analysis of the links between endothelium-dependent vasodilation indicators and the levels of high-sensitivity C-reactive protein and fractalkine/CX3CL1 in patients with acute coronary syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3679-432X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полунина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Polunina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полунина Екатерина Андреевна, д.м.н., доцент кафедры внутренних болезней педиатрического факультета</p><p>Астрахань</p></bio><bio xml:lang="en"><p>Ekaterina A. Polunina, Dr. Sci. (Med.), Associate Professor of the Department of Internal Diseases of Pediatric Faculty</p><p>Astrakhan</p></bio><email xlink:type="simple">Gilti2@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4540-619X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузьмичев</surname><given-names>К. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzmichev</surname><given-names>K. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузьмичев Кирилл Юрьевич, аспирант кафедры внутренних болезней педиатрического факультета</p><p>Астрахань</p></bio><bio xml:lang="en"><p>Kirill Yu. Kuzmichev, Medical research student of the Department of Internal Diseases of Pediatric Faculty</p><p>Astrakhan</p><p> </p></bio><email xlink:type="simple">kirill@who.net</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2395-745X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воронина</surname><given-names>Л. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Voronina</surname><given-names>L. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воронина Людмила Петровна, д.м.н., проф., профессор кафедры внутренних болезней педиатрического факультета</p><p>Астрахань</p><p> </p></bio><bio xml:lang="en"><p>Ludmila P. Voronina, Dr. Sci. (Med.), Professor, Professor of the Department of Internal Diseases of Pediatric Faculty</p><p>Astrakhan</p></bio><email xlink:type="simple">voroninaluda74@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8299-6582</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полунина</surname><given-names>О. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Polunina</surname><given-names>O. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полунина Ольга Сергеевна, д.м.н., проф., заведующая кафедрой внутренних болезней педиатрического факультета</p><p>Астрахань</p></bio><bio xml:lang="en"><p>Olga S. Polunina, Dr. Sci. (Med.), Professor, Head of the Department of Internal Diseases of Pediatric  Faculty</p><p>Astrakhan</p></bio><email xlink:type="simple">admed@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0635-3494</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Севостьянова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sevostyanova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Севостьянова Ирина Викторовна, к.м.н., доцент кафедры внутренних болезней педиатрического факультета</p></bio><bio xml:lang="en"><p>Irina V. Sevostyanova, Cand. Sci. (Med.), Associate Professor of the Department of Internal Disease of Pediatric Faculty</p><p>Astrakhan</p></bio><email xlink:type="simple">irina-nurzhanova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Астраханский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Astrakhan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2020</year></pub-date><volume>11</volume><issue>2</issue><fpage>102</fpage><lpage>110</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Полунина Е.А., Кузьмичев К.Ю., Воронина Л.П., Полунина О.С., Севостьянова И.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Полунина Е.А., Кузьмичев К.Ю., Воронина Л.П., Полунина О.С., Севостьянова И.В.</copyright-holder><copyright-holder xml:lang="en">Polunina E.A., Kuzmichev K.Y., Voronina L.P., Polunina O.S., Sevostyanova I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1068">https://www.medicalherald.ru/jour/article/view/1068</self-uri><abstract><sec><title>Цель</title><p>Цель: изучить и проанализировать наличие взаимосвязей между показателями эндотелий-зависимой вазодилатации (ЭЗВ) и уровнем фракталкина (ФН/CX3CL1) и высокочувствительного С-реактивного белка (С-РБ) у пациентов с острым коронарным синдромом (ОКС).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: среди обследуемых лиц с ОКС 63 пациента имели острый инфаркт миокарда (ИМ); 41 пациент — нестабильную стенокардию (НС), представленную у 15 человек впервые возникшей стенокардией и у 26 человек — прогрессирующей стенокардией. Группу контроля составили 20 соматически здоровых лиц. С помощью ионофоретического пробника был проведен фармакологический тест с 5 % ацетилхолином (АцХ). Уровень ФН/CX3CL1 и высокочувствительного С-РБ определялся методом иммуноферментного анализа.</p></sec><sec><title>Результаты</title><p>Результаты: у всех обследуемых пациентов с ОКС были выявлены статистически значимые, по сравнению с группой контроля, изменения в показателях ЭЗВ, а также увеличение уровня Н/CX3CL1 и высокочувствительного С-РБ. Самые выраженные изменения в значении показателей ЭЗВ и уровня ФН/CX3CL1 и высокочувствительного С-РБ среди обследуемых лиц были выявлены у пациентов с острым ИМ. Между изучаемыми показателями было выявлено наличие корреляционных связей. Сила выявленных взаимосвязей была больше среди пациентов с острым ИМ, по сравнению с пациентами с НС. При этом сила выявленных взаимосвязей у пациентов как с НС, так и с острым ИМ была большей силы между показателями ЭЗВ и уровнем ФН/CX3CL1, чем между показателями ЭЗВ и уровнем высокочувствительного С-РБ.</p></sec><sec><title>Заключение</title><p>Заключение: у пациентов с ОКС было выявлено нарушение ЭЗВ, ассоциированное с выраженностью системного воспаления. В группе пациентов с острым ИМ выраженность нарушений ЭЗВ была большей относительно пациентов с НС, что, по-видимому, было обусловлено влиянием резорбционно-некротического синдрома, потенцирующего усиление системного воспаления и повреждение эндотелия микрососудов с нарушением ЭЗВ, и подтверждено результатами корреляционного анализа. Наличие положительной взаимосвязи было выявлено между уровнем ФН/CX3CL1 и высокочувствительного С-РБ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to study and analyze the links between endothelium-dependent vasodilation (EDV) indicators and the levels of fractalkine (FN/CX3CL1) and high sensitivity C-reactive protein (hs-CRP) in patients with acute coronary syndrome (ACS).</p></sec><sec><title>Materials and methods</title><p>Materials and methods: among the examined individuals with ACS, 63 patients had acute myocardial infarction (MI); 41 patients had unstable angina (UA), represented by first – time angina in 15 people and 26 people had progressive angina. Control group included 20 healthy control individuals. Pharmacological test with 5% acetylcholine (AcH) was used to assess the functional state of the vascular endothelium. Enzyme-linked immunosorbent assay was used to determine the levels of FN/CX3CL1 and hs-CRP.</p></sec><sec><title>Results</title><p>Results: all the examined patients with ACS showed statistically significant changes in EDV indicators compared to the control group, as well as an increase in the level of FN/CX3CL1 and hs-CRP. The most pronounced changes of the values of EDV indicators and the levels of FN/CX3CL1 and hs-CRP, from the examined patients, were detected among patients with acute MI. Th e presence of correlations between the studied indicators was revealed. Th e strength of the identified links was greater among patients with acute MI, compared to patients with UA. Th e strength of the links found in patients with both UA and acute MI was greater between EDV indicators and FN/CX3CL1 levels, than between EDV indicators and hs-CRP levels.</p></sec><sec><title>Conclusions</title><p>Conclusions:all the examined patients with ACS had the EDV disorders associated with the severity of systemic infl ammation. In the group of patients with acute MI, the severity of EDV disorders was greater than in patients with UA, which was apparently due to the infl uence of the resorption-necrotic syndrome, which potentiates increased systemic infl ammation and damage to the endothelium of microvessels with EDV disorders, which was confirmed by the results of correlation analysis. A positive link was found between the levels of FN/CX3CL1 hs-CRP.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>острый коронарный синдром</kwd><kwd>острый инфаркт миокарда</kwd><kwd>нестабильная стенокардия</kwd><kwd>фракталкин/CX3CL1</kwd><kwd>высокочувствительный С-реактивный белок</kwd><kwd>эндотелий-зависимая вазодилатация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute coronary syndrome</kwd><kwd>acute myocardial infarction</kwd><kwd>unstable angina</kwd><kwd>fractalkine/CX3CL1</kwd><kwd>high-sensitivity&#13;
С-reactive protein</kwd><kwd>endothelium-dependent vasodilation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Эрлих А.Д., Мацкеплишвили С.Т., Грацианский Н.А., Бузиашвили Ю.И. Первый московский регистр острого коронарного синдрома: характеристика больных, лечение и исходы за время пребывания в стационаре. // Кардиология. - 2013. - №. 12. - С. 4-13. eLIBRARY ID:21104047.</mixed-citation><mixed-citation xml:lang="en">Érlikh A.D., Matskeplishvili S.T., Gratsianskiî N.A., Buziashvili Yu.l. First Moscow «snap-shot» register of acute coronary syndromes: characteristics of patients, management and outcomes during hospitalization. Kardiologiya.2013;12:4-13. (In Russ.). eLIBRARY ID:21104047.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Iragavarapu T., Radhakrishna T., JagadishBabu K., Sanghamitra R. Acute coronary syn-drome in young - a tertiary care centre experience with reference to coronary angiogram. // Journal of the practice of cardiovascular sciences. - 2019. - Vol. 5 (1). - P. 18-25. DOI:10.1007/s13167-017-0099-1.</mixed-citation><mixed-citation xml:lang="en">Iragavarapu T, Radhakrishna T, JagadishBabu K, Sanghamitra R. Acute coronary syndrome in young - a tertiary care centre experience with reference to coronary angiogram. Journal of the practice of cardiovascular sciences. 2019;5(1):18-25. DOI:10.1007/s13167-017-0099-1.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Martínez Linares JM., GuisadoBarrilao R., OcañaPeinado FM., Salgado Parreño FJ. Associ-ation of cardiovascular emerging risk factors with acute coronary syndrome and stroke: A case-control study. // Nurs Health Sci. - 2016. - Vol. 18 (4). - P. 488-495. DOI:10.1111/nhs.12299.</mixed-citation><mixed-citation xml:lang="en">Martínez Linares JM., GuisadoBarrilao R., OcañaPeinado FM., Salgado Parreño FJ. Associ-ation of cardiovascular emerging risk factors with acute coronary syndrome and stroke: A case-control study. Nurs Health Sci. 2016;18(4):488-495. DOI:10.1111/nhs.12299.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Barthelmes J., Nägele MP., Ludovici V., Ruschitzka F., Sudano I., Flammer AJ. Endothelial dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences. // EPMA J. - 2017. - Vol. 8 (2). - P. 99-109. DOI:10.1007/s13167-017-0099-1.</mixed-citation><mixed-citation xml:lang="en">Barthelmes J, Nägele MP, Ludovici V, Ruschitzka F, Sudano I, Flammer AJ. Endothelial dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences. EPMA J.2017;8(2):99-109. DOI:10.1007/s13167-017-0099-1.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuzawa Y., Lerman A. Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. // Coron Artery Dis. - 2014. - Vol. 25 (8). - P. 713-724. DOI:10.1097/MCA.0000000000000178.</mixed-citation><mixed-citation xml:lang="en">Matsuzawa Y, Lerman A. Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis. 2014;25(8):713-724. DOI:10.1097/MCA.0000000000000178.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kandhai-Ragunath JJ., Doggen CJ., Jørstad HT., Doggen C.J.M., Jørstad Harald., Doelman C., et al. Endothelial dysfunction after ST-segment elevation myocardial infarction and long-term outcome: a study with reactive hyperemia peripheral artery tonometry. // Rev EspCardiol (Engl Ed). - 2016. - Vol. 69 (7). - P. 664-671. DOI:10.1016/j.rec.2015.12.020.</mixed-citation><mixed-citation xml:lang="en">Kandhai-Ragunath JJ, Doggen CJ, Jørstad HT, Doggen CJM, Jørstad HТ, et al. Endothelial dysfunction after ST-segment elevation myocardial infarction and long-term outcome: a study with reactive hyperemia peripheral artery tonometry. Rev EspCardiol (Engl Ed).2016;69(7):664-671. DOI:10.1016/j.rec.2015.12.020.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Воронина Л.П. Генетические, биохимические и функциональные маркеры состояния вазорегулярующей функции эндотелия. // Сибирский медицинский журнал (Иркутск). - 2011. - № 3. - С. 29-31. eLIBRARY ID:16402161.</mixed-citation><mixed-citation xml:lang="en">Voronina L.P. Genetic, biochemical and functional markers of condition of vasoregulating function of endothelium. Sibirskii meditsinskii zhurnal (Irkutsk). 2011;3:29-31. (In Russ.).eLIBRARY ID:16402161.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Левашова О.А., Золкорняев И.Г. Оценка уровня эндотелина-1, С-реактивного белка и интенсивности десквамации эндотелия у больных ишемическим инсультом в остром периоде. // Вестник новых медицинских технологий. Электронноеиздание. - 2019. - № 4. - С. 70-74. DOI:10.24411/2075-4094-2019-16394.</mixed-citation><mixed-citation xml:lang="en">Levashova O.A., Zolkornyaev I.G. Assessment of the level of endothelin-1, C-reactive pro-tein and intensity endothelium desquamation in patients with ischemic stroke in the sharp period. Vestnik novykh meditsinskikh tekhnologii. Elektronnoe izdanie. 2019;4:70-74. (in Russ.). DOI:10.24411/2075-4094-2019-16394.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Anthony R.C., Lauren V.H., Sruti S.S., Brian S.Z. Nitric oxide and endothelial dysfunction. // Critical Care Clinics. - 2020. - Vol. 36 (2). - P. 307-321. DOI:10.1016/j.ccc.2019.12.00.</mixed-citation><mixed-citation xml:lang="en">Anthony RC, Lauren VH, Sruti SS, Brian SZ. Nitric oxide and endothelial dysfunction. Critical Care Clinics. 2020;36(2):307-321. DOI:10.1016/j.ccc.2019.12.00.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Schäfer A., Schulz C., Fraccarollo D., Tas P., Leutke M., et al. The CX3C chemokine frac-talkine induces vascular dysfunction by generation of superoxide anions. // ArteriosclerTh-rombVasc Biol. - 2007. - Vol. 27 (1). - P. 55-62. DOI:10.1161/01.ATV.0000251535.30191.6.</mixed-citation><mixed-citation xml:lang="en">Schäfer A, Schulz C, Fraccarollo D, Tas P, Leutke M, et al. The CX3C chemokine fractal-kine induces vascular dysfunction by generation of superoxide anions. Arterioscler ThrombVasc Biol. 2007;27(1):55-62. DOI:10.1161/01.ATV.0000251535.30191.6.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Umehara H., Bloom ET., Okazaki T., Nagano Y., Yoshie O., Imai T. Fractalkine in vascular biology: from basic research to clinical disease. // Arteriosclerosis, Thrombosis, and Vascular Biology. - 2004. - Vol. 24 (1). - P. 34-40. DOI:10.1161/01.ATV.0000095360.62479.1F.</mixed-citation><mixed-citation xml:lang="en">Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24(1):34-40. DOI:10.1161/01.ATV.0000095360.62479.1F.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rius C., Company C., Piqueras L., Cerdá-Nicolás JM., González C., et al. Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium. // Thorax. - 2013. - Vol. 68 (2). - P. 177-186. DOI:10.1136/thoraxjnl-2012-202212.</mixed-citation><mixed-citation xml:lang="en">Rius C, Company C, Piqueras L, Cerdá-Nicolás JM, González C, et al. Critical role of frac-talkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial en-dothelium. Thorax. 2013;68(2):177-186. DOI:10.1136/thoraxjnl-2012-202212.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yao K., Zhang S., Lu H., Hong X., Qian J., et al. Changes in fractalkine in patients with ST-elevation myocardial infarction. // Coron Artery Dis. - 2015. - Vol. 26 (6). - P. 516-520. DOI:10.1097/MCA.0000000000000273.</mixed-citation><mixed-citation xml:lang="en">Yao K, Zhang S, Lu H, Hong X, Qian J, et al. Changes in fractalkine in patients with ST-elevation myocardial infarction. Coron Artery Dis. 2015;26(6):516-520. DOI:10.1097/MCA.0000000000000273.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Xu B., Qian Y., Zhao Y., Fang Z., Tang K., et al. Prognostic value of fractalkine/CX3CL1 concentration in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. // Cytokine. - 2019. - Vol. 113. - P. 365-370. DOI:10.1016/j.cyto.2018.10.006.</mixed-citation><mixed-citation xml:lang="en">Xu B, Qian Y, Zhao Y, Fang Z, Tang K, et al. Prognostic value of fractalkine/CX3CL1 con-centration in patients with acute myocardial infarction treated with primary percutaneous co-ronary intervention. Cytokine. 2019;113:365-370. DOI:10.1016/j.cyto.2018.10.006.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">El-Mesallamy H.O., Hamdy N.M., El-Etriby A.K., Wasfey E.F. Plasma granzyme B in ST elevation myocardial infarction versus non-ST elevation acute coronary syndrome: compari-sons with IL-18 and fractalkine. // Mediators Inflamm. - 2013. - Vol. 2013. - P. 1-8. DOI:10.1155/2013/343268.</mixed-citation><mixed-citation xml:lang="en">El-Mesallamy HO, Hamdy NM, El-Etriby AK, Wasfey EF. Plasma granzyme B in ST ele-vation myocardial infarction versus non-ST elevation acute coronary syndrome: comparisons with IL-18 and fractalkine. Mediators Inflamm. 2013;2013:1-8. DOI:10.1155/2013/343268.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Стаценко М.Е., Деревянченко М.В. Роль системного воспаления в снижении эластич-ности магистральных артерий и прогрессировании эндотелиальной дисфункции у больных артериальной гипертензией в сочетании с ожирением, сахарным диабетом 2 типа. // Российский кардиологический журнал. - 2018. - № 4 (156). - С. 32-36. DOI:10.15829/1560-4071-2018-4-32-36.</mixed-citation><mixed-citation xml:lang="en">Statsenko M.E., Derevyanchenko M.V. The role of systemic inflammation in decrease of elasticity of magistral arteries and in progression of endothelial dysfunction in patients with systemic hypertension, obesity and type 2 diabetes. Rossiiskii kardiologicheskii zhurnal. 2018;4(156):32-36. (In Russ.). DOI:10.15829/1560-4071-2018-4-32-36.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kusche-Vihrog K., Urbanova K., Blanqué A., Marianne W., Schillers H., Kliche K., et al. C-reactive protein makes human endothelium stiff and tight. // Hypertension. - 2011. - Vol 57 (2). - P. 231-237. DOI:10.1161/HYPERTENSIONAHA.110.163444.</mixed-citation><mixed-citation xml:lang="en">Kusche-Vihrog K, Urbanova K, Blanqué A, Marianne W, Schillers H, et al. C-reactive pro-tein makes human endothelium stiff and tight. Hypertension. 2011;57(2):231-237. DOI:10.1161/HYPERTENSIONAHA.110.163444.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mani P., Puri R., Schwartz G.G., Nissen S.E., Shao M., Kastelein J.P., et al. Association of initial and serial C-reactive protein levels with adverse cardiovascular events and death after acute coronary syndrome. // JAMA Cardiol. - 2019. - Vol. 4 (4). - P. 314-320. DOI:10.1001/jamacardio.2019.0179.</mixed-citation><mixed-citation xml:lang="en">Mani P, Puri R, Schwartz GG, Nissen SE, Shao M, et al. Association of initial and serial C-reactive protein levels with adverse cardiovascular events and death after acute coronary syndrome. JAMA Cardiol. 2019;4(4):314-320. DOI:10.1001/jamacardio.2019.0179.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wang W., Ren D., Wang CS., Li T., Yao HC., Ma SJ. Prognostic efficacy of high-sensitivity C-reactive protein to albumin ratio in patients with acute coronary syndrome. // Biomark Med. - 2019. - Vol. 13 (10). - P. 811-820. DOI:10.2217/bmm-2018-0346.</mixed-citation><mixed-citation xml:lang="en">Wang W, Ren D, Wang CS, Li T, Yao HC, Ma SJ. Prognostic efficacy of high-sensitivity C-reactive protein to albumin ratio in patients with acute coronary syndrome. Biomark Med. 2019;13(10):811-820. DOI:10.2217/bmm-2018-0346.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Apostolakis S., Spandidos D. Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway. // Acta Pharmacol Sin. - 2013. - Vol. 34 (10). - P. 1251–1256. DOI:10.1038/aps.2013.92.</mixed-citation><mixed-citation xml:lang="en">Apostolakis S, Spandidos D. Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway. Acta Pharmacol Sin. 2013;34(10):1251–1256. DOI:10.1038/aps.2013.92.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Teixeira B.C., Lopes A.L., Macedo R.C.O., Correa C.S., Ramis T.R., et al. Inflammatory markers, endothelial function and cardiovascular risk. // J. Vasc. Bras. - 2014. - Vol. 132. - P. 108-115. DOI:10.1590/jvb.2014.054.</mixed-citation><mixed-citation xml:lang="en">Teixeira BC, Lopes AL, Macedo RCO, Correa CS, Ramis TR, et al. Inflammatory markers, endothelial function and cardiovascular risk. J. Vasc. Bras. 2014;132:108-115. DOI:10.1590/jvb.2014.054.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Storch A.S., De Mattos J.D., Alves R., Galdino I. dos S., Rocha H.N.M. Methods of Endo-thelial Function Assessment: Description and Applications. // Int. J. Cardiovasc Sci. - 2017. - Vol. 30 (3). - P. 262-273. DOI:10.5935/2359-4802.20170034.</mixed-citation><mixed-citation xml:lang="en">Storch AS, De Mattos JD, Alves R, Galdino I dos S, Rocha HNM. Methods of Endothelial Function Assessment: Description and Applications. Int. J. Cardiovasc Sci. 2017;30(3):262-273. DOI:10.5935/2359-4802.20170034.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Schneeweis C., Gräfe M., Bungenstock A., Spencer-Hänsch C., Fleck E., Goetze S. Chronic CRP-exposure inhibits VEGF-induced endothelial cell migration. // J Atheroscler Thromb. - 2010. - Vol. 17 (2). - P. 203-212. DOI:10.5551/jat.3004.</mixed-citation><mixed-citation xml:lang="en">Schneeweis C, Gräfe M, Bungenstock A, Spencer-Hänsch C, Fleck E, Goetze S. Chronic CRP-exposure inhibits VEGF-induced endothelial cell migration. J Atheroscler Thromb. 2010;17(2):203-212. DOI:10.5551/jat.3004.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
